Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 144

Results For "EY"

3100 News Found

Sun Pharma Q3 FY23 Gross Sales up 13.1%; Net profit up 5.2%
News | February 01, 2023

Sun Pharma Q3 FY23 Gross Sales up 13.1%; Net profit up 5.2%

India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year


Aptar Pharma launches highly recyclable nasal spray pump
News | January 31, 2023

Aptar Pharma launches highly recyclable nasal spray pump

APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors


NIB is playing a vital role in ensuring that quality biological products reach the health system: Dr. Mandaviya
Policy | January 29, 2023

NIB is playing a vital role in ensuring that quality biological products reach the health system: Dr. Mandaviya

It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry


Aarti Drugs Q3 FY23 revenue grows 4%
News | January 28, 2023

Aarti Drugs Q3 FY23 revenue grows 4%

Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY


Biocon Foundation bags 'IHW Gold Award for Diseases Screening Initiative of the Year' for 2022
News | January 27, 2023

Biocon Foundation bags 'IHW Gold Award for Diseases Screening Initiative of the Year' for 2022

Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India


CrisprBits develops CRISPR-based SARS-CoV2 test OmiCrisp
Biotech | January 25, 2023

CrisprBits develops CRISPR-based SARS-CoV2 test OmiCrisp

OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program


Fadnavis inaugurates 310-bed Medicover Hospitals in Navi Mumbai
Healthcare | January 25, 2023

Fadnavis inaugurates 310-bed Medicover Hospitals in Navi Mumbai

Medical Tourism will boost India’s economy


75% of asthma patients have worse symptoms during cold or flu
Healthcare | January 25, 2023

75% of asthma patients have worse symptoms during cold or flu

Asthma patients are more likely to have an asthma attack during winter


Gland Pharma’s Q3 FY23 revenue stood at Rs. 938 Cr with gross margin of 54%
News | January 24, 2023

Gland Pharma’s Q3 FY23 revenue stood at Rs. 938 Cr with gross margin of 54%

The company is adding new capabilities of Combi-line for Microsphere, additional Bag line and lyos for the Penem block in Pashamylaram facility in Hyderabad and will be earmarking capital for further building on its Biosimilar CDMO facility


SK bioscience appoints new executives
People | January 23, 2023

SK bioscience appoints new executives

Two biopharmaceutical experts join SK bioscience to strengthen the future strategies